By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PharmAthene, Inc. 

One Park Place
Suite 450
Annapolis  Maryland  21401  U.S.A.
Phone: 410-269-2600 Fax: 410-269-2601


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
PharmAthene, Inc. (PIP) Announces U.S. Bankruptcy Court Partially Lifts Litigation Stay To Permit Delaware Court To Proceed Towards Final Judgment 10/8/2014 10:47:19 AM
PharmAthene, Inc. (PIP) Awarded Contract Of Up To $28.1 Million To Develop Next Generation Thermostable Anthrax Vaccine 9/10/2014 9:17:17 AM
PharmAthene, Inc. (PIP) Release: New Non-Clinical Data Demonstrate SparVax┬« Provides Equivalent Protection In Head-To-Head Comparison With BioThrax┬« 9/9/2014 8:17:26 AM
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014 10:52:30 AM
PharmAthene, Inc. (PIP) To Present At Rodman & Renshaw And Aegis Capital Corporation 2014 Investment Conferences 9/8/2014 10:43:14 AM
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014 9:13:10 AM
Delaware Court Of Chancery Orders SIGA Technologies, Inc. (SIGA) To Pay PharmAthene, Inc. (PIP) Lump Sum Expectation Damages 8/11/2014 8:18:48 AM
PharmAthene, Inc. (PIP) Reports Second Quarter 2014 Financial And Operational Results 8/5/2014 7:13:38 AM
PharmAthene, Inc. (PIP) Granted U.S. Patent For Recombinant Bioscavenger 6/9/2014 11:07:02 AM
PharmAthene, Inc. (PIP) Presents New SparVax┬« Anthrax Vaccine Data At The FDA Medical Countermeasures Initiative Symposium 6/4/2014 9:38:06 AM
12345678910...
//-->